DexCom (NASDAQ:DXCM): 13 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $87.6 in DexCom (NASDAQ:DXCM). However, the stock price could fluctuate by $ 13.21 from the estimate as it is suggested by the standard deviation reading. The higher estimate has been put at $112 price target with the lower price estimate is calculated at $57
Many analysts have stated their opinion on the company shares. BTIG Research initiates coverage on DexCom (NASDAQ:DXCM). The rating major has initiated the coverage with buy rating on the shares. The Analysts at BTIG Research announces a current price target of $80 per share. The rating by the firm was issued on April 14, 2016. For the current week, the company shares have a recommendation consensus of Buy.
On the companys insider trading activities,The officer (SVP, Operations) of Dexcom Inc, Moy Jeffrey sold 6,910 shares at $74 on June 9, 2016. The Insider selling transaction had a total value worth of $511,340. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
DexCom (NASDAQ:DXCM) : On Monday heightened volatility was witnessed in DexCom (NASDAQ:DXCM) which led to swings in the share price. The stock opened for trading at $71.44 and hit $74.85 on the upside , eventually ending the session at $72.08, with a gain of 0.24% or 0.17 points. The heightened volatility saw the trading volume jump to 1,094,301 shares. The 52-week high of the share price is $103.29 and the company has a market cap of $6,014 million. The 52-week low of the share price is at $47.92 .
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4, DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patients receiver and an application on the patients iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers, who can remotely monitor a patients glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpots data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.